FindTrial
Sign In

Evaluation of Breast MRI

Evaluation of Breast MRI for areas of non mass enhancement in patient with suspected malignant breast mass diagnosed on mammogram and ultrasonography.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/08/044637
Enrollment
30
Registered
2022-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Control Intervention1: Association of areas of malignant non mass enhancement in patient with suspected malignant breast lesions as diagnosed on mammogram and ultrasonography. : Evaluation of non mass

Sponsors

PtB D sharma PGIMS Rohtak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Breast masses detected clinically or on ultrasound with BI-RADS staging �III.

Exclusion criteria

Exclusion criteria: � Post operative cases. � Patients with no mass lesions with BIRADS � III finding on ultrasound or X-ray mammography. � Contraindications to MRI imaging (metal debris, cardiacpace maker, claustrophobic patients etc).

Design outcomes

Primary

MeasureTime frame
Evaluation of areas of malignant non mass enhancement in patient with suspected malignant breast lesions as diagnosed on mammogram and ultrasonography.Timepoint: 4 weeks—

Secondary

MeasureTime frame
1. Evaluation of non mass enhancement Characterization of NME. Cytopathological correlation of the mass lesion as well as non enhancing lesions.Timepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr Nishant Mishra

Pt. B D sharma PGIMS, Rohtak

dragarwalshalini@gmail.com9355622099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026